Antimicrobial activity of an abiotic host defense peptide mimic

Biochimica et Biophysica Acta - Biomembranes

Volumn 1758, Issue 9, 2006, Pages 1387-1392

  Tew, Gregory N ^a   Clements, Dylan ^b   Tang, Haizong ^b   Arnt, Lachelle ^a   Scott, Richard W ^b  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b PolyMedix Inc   (United States)

Author keywords

Antibiotic resistant; Antimicrobial; Foldamer; Magainin; Phenylene ethynylene

Indexed keywords

AMPHOTERICIN; CIPROFLOXACIN; FLUCONAZOLE; LINEZOLID; METICILLIN; NORFLOXACIN; PEXIGANAN ACETATE; PHENYLENE ETHYNYLENE; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG; VANCOMYCIN;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; CANDIDA ALBICANS; CELL STRAIN 3T3; CELL STRAIN HEPG2; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG SELECTIVITY; ENTEROCOCCUS; ERYTHROCYTE; EXPERIMENTATION; FIBROBLAST; FUNGUS; HOST RESISTANCE; HUMAN; HUMAN CELL; IN VIVO STUDY; MAMMAL CELL; MAXIMUM TOLERATED DOSE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROORGANISM; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR MIMICRY; NONHUMAN; OBSERVATION; PRIORITY JOURNAL; SCREENING; STACHYBOTRYS CHARTARUM; STAPHYLOCOCCUS AUREUS; YEAST;

ANTI-INFECTIVE AGENTS; BACTERIA; DRUG RESISTANCE, MICROBIAL; FUNGI; MICROBIAL SENSITIVITY TESTS; MOLECULAR MIMICRY; PEPTIDES;

BACTERIA (MICROORGANISMS); CANDIDA ALBICANS; FUNGI; HEXAPODA; INVERTEBRATA; MAMMALIA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STACHYBOTRYS CHARTARUM; STAPHYLOCOCCUS AUREUS;

EID: 33748929145     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2006.03.001     Document Type: Article

References (34)

1. Tomasz A. Multiple-antibiotic-resistant pathogenic bacteria-A report on the Rockefeller University Workshop. New Engl. J. Med. 330 (1994) 1247-1251
2. Murray B.E. Vancomycin-resistant enterococcal infections. New Engl. J. Med. 342 (2000) 710-721
3. Sousa M.A.d., and Lencastre H.d. Evolution of sporadic isolates of methicillin-resistant staphylococcus aureus (MRSA) in hospitals and their similarities to isolates of community-acquired MRSA. J. Clin. Microbiol. 41 (2003) 3806-3815
4. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 415 (2002) 389-395
5. Boman H.G. Innate immunity and the normal microflora. Immunol. Rev. 173 (2000) 5-16
6. Hancock R.E., and Lehrer R. Cationic peptides: a new source of antibiotics. Trends Biotechnol. 16 (1998) 82-88
7. Shai Y. Mode of action of membrane active antimicrobial peptides. Biopolymers 66 (2002) 236-248
8. Lee D.L., and Hodges R.S. Structure-activity relationships of de novo designed cyclic antimicrobial peptides based on gramicidin S. Biopolymers 2003 (2003) 28-48
9. Dathe M., Wieprecht T., Nikolenko H., Handel L., Maloy W.L., MacDonald D.L., Beyermann M., and Bienert M. Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and haemolytic activity of amphipatic helical peptides. FEBS Letters 403 (1997) 208-212
10. Zasloff M. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 5449-5453
11. Chen Y., Mant C.T., Farmer S.W., Hancock R.E.W., Vasil M.L., and Hodges R.S. Rational design of α-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. J. Biol. Chem. 280 (2005) 12316-12329
12. Won H.-S., Jung S.-J., Kim H.E., Seo M.-D., and Lee B.-J. Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5. J. Biol. Chem. 279 (2004) 14784-14791
13. Hamuro Y., Schneider J.P., and DeGrado W.F. De novo design of antibacterial beta-peptides. J. Am. Chem. Soc. 121 (1999) 12200-12201
14. Porter E.A., Wang X.F., Lee H.S., Weisblum B., and Gellman S.H. Antibiotics-Non-haemolytic beta-amino-acid oligomers. Nature 404 (2000) 565
15. Liu D., and DeGrado W.F. De novo design, synthesis, and characterization of antimicrobial β-peptides. J. Am. Chem. Soc. 123 (2001) 7553-7559
16. Epand R.F., Raguse T.L., Gellman S.H., and Epand R.M. Antimicrobial 14-Helical β-peptides: potent bilayer disrupting agents. Biochemistry 43 (2004) 9527-9535
17. Patch J.A., and Barron A.E. Helical peptoid mimics of magainin-2 amide. J. Am. Chem. Soc. 125 (2003) 12092-12093
18. Tew G.N., Liu D., Chen B., Doerksen R.J., Kaplan J., Carroll P.J., Klein M.L., and DeGrado W.F. De novo design of biomimetic antimicrobial polymers. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 5110-5114
19. Liu D., Choi S., Chen B., Doerksen R.J., Clements D.J., Winkler J.D., Klein M.L., and DeGrado W.F. Nontoxic membrane-active antimicrobial arylamide oligomers, angew. Chem. Int. Ed. 43 (2004) 1158-1162
20. Tang H., Doerksen R.J., and Tew G.N. Synthesis of urea oligomers and their antibacterial activity. Chem. Commun. (2005) 1537-1539
21. Kuroda K., and DeGrado W.F. Amphiphilic polymethacrylate derivatives as antimicrobial agents. J. Am. Chem. Soc. 127 (2005) 4128-4129
22. Ilker M.F., Nusslein K., Tew G.N., and Coughlin E.B. Tuning the hemolytic and antibacterial activities of amphiphilic polynorbornene derivatives. J. Am. Chem. Soc. 126 (2004) 15870-15875
23. Gelman M.A., Weisblum B., Lynn D.M., and Gellman S.H. Biocidal activity of polystyrenes that are cationic by virtue of protonation. Org. Lett. 6 (2004) 557-560
24. Arnt L., and Tew G.N. New Poly(phenyleneethynylene)s with cationic, facially amphiphilic structures. J. Am. Chem. Soc. 124 (2002) 7664-7665
25. Arnt L., and Tew G.N. Facially amphiphilic Poly(phenyleneethynylene)s studied at the air-water interface. Langmuir 19 (2003) 2404-2408
26. Arnt L., Nusslein K., and Tew G.N. Nonhemolytic abiogenic polymers as antimicrobial peptide mimics. J. Polym. Sci., Polym. Chem. 42 (2004) 3860-3864
27. Maloy W.L., and Kari U.P. Structure-activity studies on magainins and other host-defense peptides. Biopolymers 37 (1995) 105-122
28. Mecke A., Lee D.K., Ramamoorthy A., Orr B.G., and Holl M.M.B. Membrane thinning due to antimicrobial peptide binding: an atomic force microscopy study of MSI-78 in lipid bilayers. Biophys. J. 89 (2005) 4043-4050
29. Hallock K.J., Lee D.K., and Ramamoorthy A. MSI-78, an analogue of the magainin antimicrobial peptides, disrupts lipid bilayer structure via positive curvature strain. Biophys. J. 84 (2003) 3052-3060
30. Thennarasu S., Lee D.K., Tan A., Kari U.P., and Ramamoorthy A. Antimicrobial activity and membrane selective interactions of a synthetic lipopeptide MSI-843. Biochim. Biophys. Acta Biomembr. 1711 (2005) 49-58
31. Mecke A., Lee D.K., Ramamoorthy A., Orr B.G., and Holl M.M.B. Synthetic and natural polycationic polymer nanoparticles interact selectively with fluid-phase domains of DMPC lipid bilayers. Langmuir 21 (2005) 8588-8590
32. Entenza J.M., Vouillamoz J., Glauser M.P., and Moreillon P. Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant staphylococcus aureus. Antimicrob. Agents Chemother. 41 (1997) 1662-1667
33. Arnt L., Rennie J., Linser S., Willumeit R., and Tew G.N. Membrane activity of biomimetic facially amphiphilic antibiotics. J. Phys. Chem. B. 110 (2006) 3527-3532
34. Chen X., Tang H., Even M.A., Wang J., Tew G.N., and Chen Z. Observing a molecular knife at work. J. Am. Chem. Soc. 128 (2006) 2711-2714